A critical analysis of urea transporter B inhibitors: molecular fingerprints,pharmacophore features for the development of next-generation diuretics

Molecular Diversity - Urea transporter is a membrane transport protein. It is involved in the transferring of urea across the cell membrane in humans. Along with urea transporter A, urea...     

All-optical carry lookahead adder with the help of terahertz optical asymmetric demultiplexer

An all-optical model of carry lookahead adder (CLA) implemented with a semiconductor optical amplifier (SOA)-assisted Sagnac interferometer (TOAD) is presented. The model accounts for the SOA small signal gain, linewidth enhancement factor, the switching pulses energy and width and the Sagnac loop asymmetry. Adder is a very basic component in a central processing unit. The CLA is the highest speed adder nowadays. Theoritical model is presented and verified through numerical simulation. The method promises both higher processing speed and accuracy. The model can be enhanced the functionality in which carry lookahead adder is the basic building block.     

Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings

PSTi8 is a pancreastatin inhibitory peptide that is effective in the treatment of diabetic models. This study investigates the pharmacokinetic (PK) properties of PSTi8 in Sprague Dawley rats, for the first time. In vitro and in vivo PK studies were performed to evaluate the solubility, stability in plasma and liver microsomes, plasma protein binding, blood–plasma partitioning, bioavailability, dose proportionality, and gender difference in PK. Samples were analyzed using the validated LC-MS/MS method. The solubility of PSTi8 was found to be 9.30 and 25.75 mg/mL in simulated gastric and intestinal fluids, respectively. The protein binding of PSTi8 was estimated as >69% in rat plasma. PSTi8 showed high stability in rat plasma and liver microsomes and the blood–plasma partitioning was >2. The bioavailability of PSTi8 after intraperitoneal and subcutaneous administration was found to be 95.00 ± 12.15 and 78.47 ± 17.72%, respectively, in rats. PSTi8 showed non-linear PK in dose proportionality studies, and has no gender difference in the PK behavior in rats. The high bioavailability of PSTi8 can be due to high water solubility and plasma protein binding, low clearance and volume of distribution. Our in vitro and in vivo findings support the development of PSTi8 as an antidiabetic agent.     

Selective Synthesis of 6′‐Arylidene‐1‐aryl‐3‐aryl‐spiro[pyrrolizidine‐2,2′‐cyclohexanone] by Cycloaddition of Azomethine Ylides to Dibenzylidene Cyclohexanone

Azomethine ylides derived in situ from l ‐proline and aryl aldehydes underwent regioselective and stereoselective cycloadditions with diaryl cycloahexanone to form a series of spiro‐pyrrolizidine compounds. By using equimolar proportions of the reactants in DMF, only a single mono‐adduct, namely 6′‐arylidene‐1‐aryl‐3‐aryl‐spiro[pyrrolizidine‐2,2′‐cyclohexanone], was formed, the second double bond in the dipolarophile remaining unaffected. Structure elucidation was achieved by detailed spectroscopic analyses and XRD studies. Interesting solid‐state structural characteristics were revealed by XRD analysis.     

Synthesis and Structural Characterisation of Two Copper(II) Complexes of <Emphasis Type="Italic">N</Emphasis>-(1-acetyl-2-propylidene) (2-pyridylmethyl) amine

Two new complexes [CuBr(C₁₁H₁₃N₂O)] (1) and [Cu(NCO)(C₁₁H₁₃N₂O)] (2) containing the tridentate Schiff base ligand, N-(1-acetyl-2-propylidene)(2-pyridylmethyl) amine which is the 1:1 condensation product of acetylacetone and 2-aminomethylpyridine, have been synthesised and characterised by elemental analysis, IR and electronic spectra, electrochemical study and single crystal X-ray diffraction study. Crystal structures reveal that the copper atom in both the complexes are in square geometry formed by the N₂O donor set of the Schiff base and a bromine atom in 1 and one cyanate ligand in 2. Both bromide and isocyanate ligands act in a terminal monodentate fashion.     

One Novel Cu(II)–Amino Acid Schiff Base Complex Derived from Salicylaldehyde and L-Serine: Identification of Unusual Monodentate 4,4′-Bipyridine

One novel copper(II) complex [Cu(L)(4,4′-bipy)](ClO₄) (1), (where L: tridentate Schiff base derived from salicylaldehyde and L-serine) has been synthesised and characterised by spectroscopic and electrochemical studies. The single-crystal structure of the complex was determined. The crystal structure features the presence of [Cu(L)(4,4′-bipy)]⁺ cations and ClO₄⁻ anions aggregated by hydrogen bonding. Here, 4,4′-bipyridine functions as a monodentate ligand, which appears to be an unusual phenomenon.     

Identification of molecular fingerprints of phenylindole derivatives as cytotoxic agents: a multi-QSAR approach

Phenylindole is reported to be an interesting scaffold having promising cytotoxic activities and can overcome the cancer drug resistance possibly via binding to the colchicine binding site of tubulin. In order to find out the molecular fingerprints for the better cytotoxic activity of phenylindole derivatives, multiple validated chemometric modeling approaches namely hologram QSAR (HQSAR), Bayesian classification model, and pharmacophore mapping analyses were applied into a dataset of 102 phenylindole derivatives. The final HQSAR model shows good statistical significance (Q²?=?0.760; R²_Train?=?0.868; R²_Test?=?0.660), and the best pharmacophore hypothesis has the highest regression coefficient value (r?=?0.975) and the lowest RMS value of 0.679. Moreover, the Bayesian model is also statistically validated and robust to discriminate the cytotoxic and non-cytotoxic phenylindoles. These studies suggest that the amine group should be unsubstituted for retaining higher cytotoxicity. The pharmacophore mapping and Bayesian classification study suggest the importance of 2-phenyl group as a ring aromatic feature conducive to cytotoxicity. The steric and hydrophobic effect of long chain linear alkyl group has a positive influence on cytotoxicity as evidenced by the multi-QSAR study. Therefore, this multi-QSAR modeling reported here is beneficial in designing potential phenylindole cytotoxic agents in future.     

1,3-Dipolar cycloadditions of nonstabilized azomethine ylides to planar chalcones via regio- and stereoselective route: A three-component strategy

Simple and efficient strategies toward the synthesis of trisubstituted pyrrolizidines and disubstituted oxazolidine systems by 1,3-dipolar cycloaddition reactions using arylaldehydes and α-amino acids have been developed, followed by a one-pot, three-component strategy. Electron-deficient dipolarophiles, chalcones, were reacted with nonstabilized azomethine ylides derived from arylaldehyde and L-proline in dry dimethyl formamide, leading to substituted pyrrolizidines. The route to substituted oxazolidines involved cycloaddition to the C?O bond of a second molecule of the aldehyde. The structures and stereochemistry of the cycloadducts were established by infrared (IR), NMR spectroscopy, and single-crystal x-ray crystallographic analyses. Condensed Fukui functions and local electrophilicity indices have been computed to characterize the reactive sites and predict the preferred interactions of azomethine ylides to planar chalcones. The softness-matching indices have been evaluated to determine the regioselectivity of the cycloaddition reactions. The theoretical predictions were found to be in complete agreement with the experimental results, implying that the density functional theory (DFT)-based reactivity indices correctly predict the regioselectivities of 1,3-dipolar cycloadditions of azomethine ylides to planar chalcones. The frontier molecular orbital (FMO) energies, electronic chemical potentials, chemical hardness, chemical softness, and global electrophilicity indices of azomethine ylides have been calculated at the DFT/B3LYP/6-31 + G (d, p) level of theory.